Letter by Marlu et al Regarding Article, “Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate: A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects”-Reference-Cited by-同舟云学术

Letter by Marlu et al Regarding Article, “Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate: A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects”

Published:2012-04-24 Issue:16 Volume:125 Page:
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Marlu Raphael¹,Hodaj Enkelejda²,Pernod Gilles³

Affiliation:

1. Haemostasis Unit University Hospital/Joseph Fourier Grenoble 1 University Grenoble, France (Marlu)

2. Clinical Research Centre Inserm CIC03 University Hospital Grenoble, France (Hodaj)

3. Vascular Medical Unit University Hospital/Joseph Fourier Grenoble 1 University Grenoble, France (Pernod)

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.111.073122

Reference5 articles.

1. Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate

2. Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage

3. Assessment of laboratory assays to measure rivaroxaban – an oral, direct factor Xa inhibitor

4. Evaluation of Prothrombin Complex Concentrate and Recombinant Activated Factor VII to Reverse Rivaroxaban in a Rabbit Model

5. Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With the Direct Thrombin Inhibitor Dabigatran

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Bleeding Complications in Patients Taking Direct Oral Anticoagulants at a Large Tertiary Academic Medical Center;Current Emergency and Hospital Medicine Reports;2015-06-13

2. Practical considerations in emergency management of bleeding in the setting of target-specific oral anticoagulants;The American Journal of Emergency Medicine;2014-04

3. New Anticoagulants and Antiplatelet Agents: A Primer for the Clinical Gastroenterologist;American Journal of Gastroenterology;2014-01

4. Rivaroxaban: A Review of its Use in the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation;Drugs;2013-05

5. Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With Rivaroxaban;Stroke;2013-03